Linked Life Data

20510966

Source:http://linkedlifedata.com/resource/pubmed/id/20510966

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-5-31
pubmed:abstractText
Despite widespread acceptance of the value of screening for and treating gestational diabetes mellitus (GDM) in the United States, evidence concerning a benefit to this approach has been lacking. Confounding variables have specifically raised the question as to whether mild forms of carbohydrate intolerance are associated with increased perinatal and maternal risks. The findings of 2 recently conducted large-scale randomized clinical trials both indicate significant reductions in fetal overgrowth, shoulder dystocia, and preeclampsia with treatment. Thus, compelling evidence now exists that the benefit outweighs risks associated with the treatment of mild GDM.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1097-6868
pubmed:author
pubmed:copyrightInfo
Copyright 2010 Mosby, Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
202
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
649-53
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Is there a benefit to the treatment of mild gestational diabetes mellitus?
pubmed:affiliation
Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA. mark.landon@osumc.edu
pubmed:publicationType
Journal Article, Review